CSIMarket
 


Immuron Limited  (IMRN)
Other Ticker:  
 


Immuron Limited's EBITDA Margin by quarter

Trends, Rankings, Statistics



IMRN EBITDA Margin 0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2022)
IV. Quarter
0
III. Quarter
Y / Y Revenue Change - - - - -
Seq. Revenue Change - - - - -
Revenue In Millions $0.00 $0.00 $0.00 $0.00 $0.00
EBITDA Margin - - - - -
EBITDA Margin Total Ranking # # # # #
EBITDA In Millions $0.00 $0.00 $0.00 $0.00 $0.00
Y / Y EBITDA Change - - - - -
Seq. EBITDA Change - - - - -


Commenting Third Quarter 2023 EBITDA Margin
Immuron Limited achived higher Operating Loss of 0 then a $0.00 millions reported a quarter before.

Observing third quarter 2023 results within Major Pharmaceutical Preparations industry Immuron Limited has achieved highest EBITDA Margin. While overall EBITDA Margin ranking remained unchanged compare to previous quarter at no. .
Learn about Operating Margin
IMRN's EBITDA Margin third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

EBITDA Margin Statistics
High Average Low
0 % 0 % 0 %
 




Other EBITDA Margin Profitability Ratios
IMRN's Cumulative EBITDA Margin
Major Pharmaceutical Preparations Industry EBITDA Margin Trends and Statistics
Healthcare Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
IMRN's EBITDA Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for IMRN's Competitors
EBITDA Margin Profit Margin for Immuron Limited's Suppliers
EBITDA Margin Profit Margin for IMRN's Customers

You may also want to know
IMRN's Annual Growth Rates IMRN's Profitability Ratios IMRN's Asset Turnover Ratio IMRN's Dividend Growth
IMRN's Roe IMRN's Valuation Ratios IMRN's Financial Strength Ratios IMRN's EBITDA Growth
IMRN's Roa IMRN's Inventory Turnover Ratio IMRN's Growth Rates IMRN's Dividend Comparisons


Companies with similar EBITDA Margin in the quarter ending 0, within Major Pharmaceutical Preparations Industry EBITDA Margin0 MRQ EBITDA0 MRQ Revenue




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com